Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BI Nutraceuticals is a leading global supplier of botanical ingredients, providing a comprehensive range of powders, extracts, vitamins, minerals, and probiotics to the dietary supplement, food, and beverage industries. The company is widely recognized for its rigorous quality control standards, specifically its proprietary Identilok® species identification process, which ensures the authenticity and purity of botanical raw materials. In addition to ingredient supply, BI offers specialized manufacturing services including custom milling, blending, and the Protexx HP® organic steam sterilization method. The company maintains a global footprint with multiple manufacturing and distribution facilities designed to meet stringent regulatory requirements. In 2019, BI Nutraceuticals was acquired by Lallemand, a global leader in yeast and bacteria production, allowing the company to further integrate its botanical expertise with advanced probiotic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BI Nutraceuticals.